Bentham Science Logo

Track Your Manuscript:


Current Gene Therapy

Volume 21, 5 Issues, 2021
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access

Call for Editors

Current Gene Therapy is recruiting Editors in the following Hot Areas of the Journal. If you are interested to join, then please submit your details for the Editor in Chief’s consideration below.

  1. Cancer Gene Therapy
  2. Carcinogenesis
  3. Epigenetics
  4. Gene Editing
  5. Gene Expression Analysis
  6. Gene Mutation
  7. Gene Replacement Therapy
  8. Gene Therapy Vectors
  9. Genetic Disorders
  10. Genetic Engineering
  11. Hemophilia
  12. Human Gene Therapy
  13. Lentiviral Gene Therapy
  14. Plasmid DNA
  15. RNA-Based Therapeutics
  16. RNAi-Based Gene Therapy
  17. Stem Cell Gene Therapy
  18. Systemic Gene Delivery
  19. Transcription Factors
  20. Viral Vectors for Gene Therapy

* If you are willing to become an Editor, in any other section (not listed above), which you feel is relevant to Journals' scope, then please inform us by choosing the “Others” option from the drop down list when you are filling the form below.

Responsibilities:
  1. Editors are responsible to contribute 1 thematic issue each year in a their area of interest. We expect to receive thematic issue proposals from section editors within 4 months of their appointment, a list of potential authors (with a respectable h-index) within 6 months and the complete thematic issue within 9 months.
  2. Editors are also expected to occasionally solicit/contribute review articles.
  3. Promote the thematic issue amongst the research community to increase its visibility
Selection Criteria:

Selection by the Editor-in-Chief will be based on, but not limited to, the following factors:

  • Interested candidates must at least hold a Doctorate degree
  • A broad and extensive knowledge of the field
  • Previous editorial experience would be desirable


Editor Details

* These fields are mandatory.








Editor-in-Chief

Liang Cheng
College of Bioinformatics Science and Technology
Harbin Medical University
Harbin, Heilongjiang
(China)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Gene Therapy Journal was launched in 2001. Dr. Ignacio Anegon was the founding editor of the journal.
New eBook

Probing Intracellular Regulation



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

April-2021-ban

Related Journals

Related eBooks

eBooks Catalog